Connect Biopharma Holdings Limited

    Jurisdiction
    China
    ISIN
    US2075231017 (CNTB)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €22.38M
    Gross margin
    95.6%
    EBIT
    -€50.01M
    EBIT margin
    -223.4%
    Net income
    -€49.27M
    Net margin
    -220.1%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €8.63M -61.5% -€40.52M -17.8%
    €14.23M +65.0% -€38.35M -5.3%
    €20.10M +41.2% -€45.54M +18.7%

    Dividends

    No dividend payouts

    Earnings Calls

    Latest earnings call: September 13, 2022

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 115K $63.14K -20K Sell

    Add to watchlist

    Notifications